Insights

Strategic Merger Obalon merged with ReShape Lifesciences in January 2021, presenting a potential cross-sell opportunity for weight-loss technology and post-merger integration services, as well as leveraging a combined customer base and clinical networks.

Regulatory Scrutiny Multiple investigations into fiduciary duties and securities laws surrounding the merger indicate heightened governance risk and potential reputational exposure; this creates an opening to offer compliance, governance, and investor relations support services.

Clinical Collaboration With a history of working closely with clinicians on gastric balloon technology, there is a strong path for partnerships with healthcare providers and hospital systems for training, device trials, and expanded adoption of obesity-related therapies.

Financial Scale Gap Revenue is in the low millions while funding exceeds two hundred million, highlighting opportunities to engage in financial planning, capital advisory, and scalable solutions that align with a smaller innovator seeking efficiency and growth.

Tech Stack Fit The existing technology footprint (Salesforce, Power BI, Microsoft SQL Server, VMware, and digital optimization tools) suggests opportunities to offer integrated analytics, CRM optimization, data security enhancements, and cloud modernization services to accelerate go-to-market and commercialization efforts.

Similar companies to Obalon Therapeutics

Obalon Therapeutics Tech Stack

Obalon Therapeutics uses 8 technology products and services including Optimizely, Crazy Egg, Power BI, and more. Explore Obalon Therapeutics's tech stack below.

Media & News

Obalon Therapeutics's Email Address Formats

Obalon Therapeutics uses at least 3 email formats:
Obalon Therapeutics Email FormatsExamplePercentage
FLast@obalon.comJDoe@obalon.com
78%
Last@obalon.comDoe@obalon.com
20%
FirstL@obalon.comJohnD@obalon.com
2%

Frequently Asked Questions

What is Obalon Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact Obalon Therapeutics's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Obalon Therapeutics's stock symbol?

Minus sign iconPlus sign icon
Obalon Therapeutics is a publicly traded company; the company's stock symbol is RSLS.

What is Obalon Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
Obalon Therapeutics's official website is obalon.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Obalon Therapeutics generate?

Minus sign iconPlus sign icon
As of October 2026, Obalon Therapeutics's annual revenue is estimated to be $1M - $10M.

What is Obalon Therapeutics's SIC code and NAICS code?

Minus sign iconPlus sign icon
Obalon Therapeutics's SIC code is 2835 - In Vitro and In Vivo Diagnostic Substances and NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Obalon Therapeutics have currently?

Minus sign iconPlus sign icon
As of October 2026, Obalon Therapeutics has approximately 18 employees across 2 continents, including North America and Europe. Key team members include Consultant, Advisor: P. K., Executive: T. A. and Manufacturing Technician: V. T. Explore Obalon Therapeutics's employee directory with LeadIQ.

What industry does Obalon Therapeutics belong to?

Minus sign iconPlus sign icon
Obalon Therapeutics operates in the Medical Equipment Manufacturing industry.

What technology does Obalon Therapeutics use?

Minus sign iconPlus sign icon
Obalon Therapeutics's tech stack includes Optimizely, Crazy Egg, Power BI, WordPress, Salesforce, Microsoft SQL Server, Microsoft 365 and VMware.

What is Obalon Therapeutics's email format?

Minus sign iconPlus sign icon
Obalon Therapeutics's email format typically follows the pattern of FLast@obalon.com. Find more Obalon Therapeutics email formats with LeadIQ.

How much funding has Obalon Therapeutics raised to date?

Minus sign iconPlus sign icon
As of October 2026, Obalon Therapeutics has raised $201M in funding. The last funding round occurred on Aug 06, 2019 for $17M.

When was Obalon Therapeutics founded?

Minus sign iconPlus sign icon
Obalon Therapeutics was founded in 2008.
Obalon Therapeutics logo

Obalon Therapeutics

Medical Equipment ManufacturingCalifornia, United States11-50 Employees

Obalon Therapeutics is a medical equipment manufacturing company focused on gastric balloon technology. It describes itself as engineering-driven and collaborates with clinicians to develop medical products intended to address chronic disease. The company is based in Carlsbad, California (in the San Diego area) and has 11 to 50 employees; its website is https://obalon.com. In January 2021, Obalon Therapeutics merged with ReShape Lifesciences Inc. in an all-stock transaction. Reported revenue is in the low millions of dollars (range $1M-$10M) and total funding amounts to $17 million.

Section iconCompany Overview

Phone number
Website
obalon.com
SIC Code
2835 - In Vitro and In Vivo Diagnostic Substances
Stock Symbol
RSLS
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Founded
2008
Employees
11-50

Section iconFunding & Financials

  • $201M

    Obalon Therapeutics has raised a total of $201M of funding over 13 rounds. Their latest funding round was raised on Aug 06, 2019 in the amount of $17M as a Post IPO Equity.

  • $1M - $10M

    Obalon Therapeutics's revenue is estimated to be in the range of $1M - $10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.